The FDAnews Webinar Training Pass program offers year-round, unrestricted access to any of the hundreds of webinars listed below. These training programs feature thought leadership and best practices from top consultants, expert speakers and current and former FDA officials. New webinars are offered every month, along with access to the Webinar Training Pass archive.
BUY NOW Single-User 1-Year Unlimited Access $1,362
If you are already a Training Pass member, login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video, click the "Download Presentation" link.
Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Russ Titsch, Business Development Director at russ.titsch@wcgclinical.com or +1 703.538.7651 to receive a custom quote.
Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.
If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.
Webinar Training Pass
Recorded on: March 18, 2019
Description: Regulatory expert Christine Kirk provides an update on recent developments in OTC regulation. She covers:
- Significant OTC monograph reform legislation currently pending in Congress (H.R. 269);
- FDA draft guidance on OTC innovation;
- Recent OTC-related enforcement actions; and
- Common areas of confusion and key compliance issues.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Christine Kirk, Food and Drug Group associate, Arnall Golden Gregory healthcare practice
Recorded on: Feb. 27, 2019
Description: Regulatory experts Bethany Hills and Aaron Josephson outline the FDA’s evolving compliance policies for devicemakers. They discuss:
- What areas the FDA targeted in inspections in 2018 and has focused on for enforcement in 2019;
- The nuances in compliance areas that create risk and should be closely monitored in your quality system; and
- Enforcement tools the FDA will be using in 2019 to ensure compliance.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Bethany J. Hills, Chair, FDA Practice, Mintz Levin, and Aaron Josephson, Senior Director, Mintz Levin
Recorded on: Feb. 20, 2019
Description: Regulatory expert Mary Vater shares best practices for preparing and submitting 510(k) applications as FDA policies evolve. She discusses:
- What specific changes the FDA has made to the 510(k) process;
- How to identify a suitable and favorable predicate device;
- How the FDA is addressing the changing biocompatibility requirements; and
- The best time to file your pre-submission.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Mary Vater, Medical Device Consultant, Medical Device Academy, Inc.
Recorded on: Feb. 19, 2019
Description: Attorney and pharmacist Lee Rosebush addresses newly proposed standards for outsourcing. He discusses:
- Implementing best practices to protect against contamination;
- Ensuring that a compounder conducts sterility assurance activities for sterile products and microbiological quality activities for non-sterile products; and
- Conducting annual quality standard evaluations of drug products.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Lee H. Rosebush, Partner, Baker Hostetler
Recorded on: Feb. 14, 2019
Description: Regulatory experts Nicholas Mitrokostas and Daniel Orr discuss recent developments in regulation of biosimilars. They cover:
- Modernizing policies governing the development of biosimilars to make it more efficient;
- Educating clinicians, payers and patients about biosimilar products and the rigorous evaluation they must go through; and
- Modernizing regulatory policies to accommodate new scientific tools that better enable comparison between biosimilars and reference products that may reduce the need for clinical studies.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Nicholas Mitrokostas, Partner, Goodwin Procter LLP, and Daniel Orr, Partner, Womble Bond Dickinson LLP
Recorded on: Feb. 13, 2019
Description: Supply chain consultant Evren Ozkaya explains how to prepare for upcoming serialization and track-and-trace requirements. He discusses:
- Lessons learned from the first five years of implementation of the Drug Supply Chain Security Act;
- How to setup the right foundation for digital supply chain management; and
- New technologies (e.g., Blockchain, Internet of Things) that will define supply chain capabilities.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Evren Ozkaya, Founder & CEO, Supply Chain Wizard, LLC
Recorded on: Jan. 30, 2019
Description: Regulatory expert James Rogers explores the nature and regulation of software as a medical device (SaMD). He discusses:
- The process for classifying an SaMD based on U.S. and international guidance;
- How a company’s use of a software product impacts the classification of SaMD;
- When a purchased software product becomes an SaMD; and
- Remediation approaches to resolve SaMD compliance issues.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: James Rogers, Founder, Compass Life Science Solutions
Recorded on: Jan. 29, 2019
Description: Regulatory expert Tiffany Guckin explains the nature and content of investigator’s brochures (IB) and IND annual reports. She discusses:
- The importance of annual reports to the FDA and sponsors;
- Structure and content of an IB per ICH E6 (R2);
- How to ensure you are accurately representing your investigation to potential subjects; and
- Best practices that can be included in SOPs or other regulatory processes.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Tiffany Guckin, Associate Director of Regulatory Affairs, Invicro
Recorded on: Jan. 17, 2019
Description: Regulatory expert Keith Webber discusses new ICH guidances being developed. He covers:
- The nuances in global harmonization of the biopharmaceutics classification system for requesting biowaivers under ICH M9;
- What to expect for the global harmonization of bioanalytical method validation under ICH M10; and
- Why the ICH Q12 guideline is a game-changer for pharmaceutical regulatory and quality professionals.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Keith Webber, Vice President of Biotechnology, Lachman Consultant Services, Inc.
Recorded on: Jan. 15, 2019
Description: Cybersecurity expert Norma Krayem discusses the rapidly changing global IT security regulatory landscape. She covers:
- Cybersecurity-triggered changes in the interpretation of HIPAA and enforcement by the HHS Office of Civil Rights;
- Cybersecurity as an enterprise risk management issue affecting security, risk and privacy functions in device firms;
- FDA’s evolving focus on cybersecurity and how it impacts the risk, responsibilities and regulation of companies; and
- The Cybersecurity Information Sharing Act (CISA) and the Protected Critical Infrastructure Information (PCII) as potential “safe harbors.”
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Norma Krayem, Senior Policy Advisor and Co-Chair, Cybersecurity and Privacy Team, Holland & Knight